Does Ribavirin Interact with Didanosine?
Ribavirin and Didanosine have a contraindicated drug interaction according to U.S. FDA drug labeling data. Coadministration increases didanosine exposure and active metabolite, causing or worsening clinical toxicities including fatal hepatic failure, peripheral neuropathy, pancreatitis, and symptomatic hyperlactatemia/lactic acidosis. The mechanism involves increased exposure to didanosine and its active metabolite (dideoxyadenosine 5'-triphosphate). Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Contraindicated
- Ribavirin Class
- Nucleoside Analog Antiviral
- Management
- Do not take together
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Ribavirin and Didanosine occurs because increased exposure to didanosine and its active metabolite (dideoxyadenosine 5'-triphosphate). Clinically, this means coadministration increases didanosine exposure and active metabolite, causing or worsening clinical toxicities including fatal hepatic failure, peripheral neuropathy, pancreatitis, and symptomatic hyperlactatemia/lactic acidosis. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.
What To Tell Your Doctor or Pharmacist
If you are taking Ribavirin and your doctor is considering prescribing Didanosine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask about alternative medications that do not interact with your current regimen
- Ask how frequently you should be monitored while these are co-prescribed
- Never stop or change either medication without first consulting your healthcare provider